# The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)

> **NCT02432768** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 22 (actual)

## Conditions studied

- Glycogen Storage Disease Type V

## Interventions

- **DRUG:** Triheptanoin
- **OTHER:** Placebo oil

## Key facts

- **NCT ID:** NCT02432768
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2018-04
- **Final completion:** 2019-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-10-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432768, "The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02432768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*